KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Clinical trials for KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN explained in plain language.

Never miss a new study

Get alerted when new KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN trials appear

Sign up with your email to follow new studies for KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Early trial tests re-engineered immune cells to battle multiple cancers

Disease control Terminated

This early-phase study tested the safety of a new cell therapy for adults with advanced cancers that have a specific marker called KK-LC-1. Doctors collected a patient's own immune cells, modified them in a lab to better recognize and attack cancer cells, and then infused them ba…

Matched conditions: KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 04, 2026 10:06 UTC

KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN

Get alerted when new KITA-KYUSHU LUNG CANCER ANTIGEN 1, HUMAN trials appear

Early trial tests re-engineered immune cells to battle multiple cancers